Yesterday, the Florida House Legislature voted
93-22 passing HB 19. The bill creates programs and processes for importing
prescription drugs from Canada, as well as from other countries. HB 19 actually
calls for the creation of two programs, which I have summarized below. For a
deep dive, you should read the Staff
Analysis from the Florida House of Representatives.
Prescription Drug Importation Program (CPDIP)
If HB 19 becomes law, the Florida Agency for Health Care
Administration (AHCA) will create processes that meet the safety protocols
called for in the bill, which include inspections and testing of drugs, to
allow registered wholesale pharmacies to import from Florida-registered
Canadian wholesalers. In this program, lower drug prices will save taxpayers
money for government funded-entities, such as county health departments, free
clinics, and the Department of Corrections.
(more…)Tagged with: Florida
Properly licensed foreign pharmacies help Americans access
medicines that they can’t afford here. Counterfeit drug makers and sellers,
fentanyl and opioid dealers, and dangerous pharmacy websites are worthy targets
of serious regulatory or criminal enforcement actions. There’s no gray there.
An article I wrote that was recently published in The Nation hopefully brings to greater public attention the FDA’s conflation of clearly safe channels for personal prescription imports with counterfeit drugs, the opioid crisis, and rogue online pharmacies. That conflation, one associated with the media relations work of the pharmaceutical industry – is used to justify FDA enforcement actions that exacerbate the crisis of high drug prices by threatening programs that facilitate prescription fulfillment from foreign, licensed pharmacies.
(more…)Tagged with: CanaRx, Counterfeit Drugs, FDA, fentanyl, The Nation
Earlier this week, a report (the
“FGI Report”) opposing prescription drug importation proposals was released
by the law firm of Freeh, Sporkin and Sullivan LLP and the Freeh Group International.
Both organizations are headed by former FBI Director, Louis Freeh. I’m hesitant
to criticize reports authored by dedicated Americans who spent years in public
service protecting the safety of the American people in federal law enforcement.
On the other hand, the intent of tacking the name of a venerated American
patriot on a report that mirrors
the lobbying agenda of the pharmaceutical industry is clearly being used to
deter voices opposed to that agenda.
Summing it all up: this report was commissioned, I believe, by the drug company-funded group Partnership for Safe Medicines or a similar organization. As noted in the report’s title, it’s an addendum to an earlier report published in late 2017, one that was promoted at a Partnership for Safe Medicines media event at the National Press Club.
(more…)Tagged with: Alex Azar, FGI report, Louis Freeh, Partnership for Safe Medicines
Senator Chuck Grassley (R-IA), who introduced the Safe and Affordable Drugs from Canada Act of 2019, may well emerge as a major champion for Americans who import medicine because the prices are too high here in the U.S.
An astounding thing happened during the Senate Finance Committee hearing on drug prices this past Tuesday. Committee Chairman Grassley asked one of the witnesses, a mother struggling with the cost of insulin for her young adult son, if she had considered importing medicine to afford it.
Think about that.
Under most circumstances, according to the FDA, it’s illegal to import medicine for personal use. And yet at a high-profile Senate committee hearing, the venerable Sen. Grassley seemed genuinely curious why Ms. Sego didn’t get lower-cost medication online from another country.
(more…)Tagged with: American Diabetes Association, Insulin, Senator Chuck Grassley
In the first
two weeks of January, the prospects for drug importation to help alleviate high
drug prices in the U.S. are looking good. Before summarizing recent
developments, I’ll just note that millions of Americans who can’t afford
medicines and want to save money continue to use personal drug importation,
despite the federal prohibitions. This includes physically traveling across the
border to buy from Canadian or Mexican pharmacies, through international air
travel, and ordering from international online pharmacies.
Lucia Mueller blogged about an important survey by the Campaign for Personal
Prescription Importation in which 94%
of respondents affirmed that cost is the #1 reason they rely on importation
through international online pharmacies.
Inquirer reported on Americans with Medicare falling through the
cracks on drugs dropped from formularies, particularly when they are prescribed
off-label, facing high costs and looking internationally for relief. As
reported, savings are even greater when Americans buy generic versions
overseas, of drugs that are still under patent domestically.
lot of buzz in Congress, states, and the White House on the issue of drug
importation right now. Hopefully, current laws will be amended this year to
make importation expressly permitted instead of merely tolerated.
(more…)Tagged with: Alex Azar, Daraprim, Donald Trump, Scott Gottlieb
It’s no secret Americans are struggling to afford their medications. A quick skim of crowdfunding websites, such as GoFundMe.com and Fundly.com, sets the grim scene of rising prescription drug costs in the United States. As a result, many Americans are ordering from online pharmacies located in other countries that offer the price relief folks can rarely swing here at home without the aid of insurance or strategic use of discount coupons.
A 2019 survey conducted by the Campaign for Personal Prescription Importation shows that cost is the top reason more and more Americans are ordering their prescriptions from online pharmacies in Canada. 94% of Americans cite high drug prices in the U.S. as reason for ordering from abroad.
(more…)Tagged with: campaign for personal prescription importation, Go Fund Me, Medicare, survey